Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW – Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 16,531 shares, a decrease of 66.2% from the May 31st total of 48,965 shares. Based on an average daily volume of 10,212 shares, the short-interest ratio is currently 1.6 days.
Rocket Pharmaceuticals Trading Down 20.3%
Shares of Rocket Pharmaceuticals stock traded down $0.00 on Friday, hitting $0.01. 17,105 shares of the company’s stock were exchanged, compared to its average volume of 27,838. The company has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.02. Rocket Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.08.
Rocket Pharmaceuticals Company Profile
Rocket Pharmaceuticals, Inc is a clinical-stage biotechnology company focused on developing and commercializing novel, life-transforming gene therapies for rare pediatric diseases. The company’s research and development activities center on inherited genetic disorders, leveraging both lentiviral and adeno-associated virus (AAV) platforms to deliver corrective genes. Rocket’s lead programs include treatments for conditions such as Fanconi anemia, leukocyte adhesion deficiency-I (LAD-I), Danon disease and mucopolysaccharidosis type IIIA (MPS IIIA), each of which represents a high unmet medical need in the pediatric population.
Founded in 2015, Rocket Pharmaceuticals went public in 2018 and trades on the Nasdaq under the ticker symbol RCKTW.
Featured Articles
- Five stocks we like better than Rocket Pharmaceuticals
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Rocket Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
